FR941107-2-00233 FR941107-2-00112 23. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR&hyph;13):1&hyph;132, and Federal Register 1994;59(208):54242&hyph;54303. 24. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34:681&hyph;686,691&hyph;695. 25. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR 1986;35:221&hyph;223. 26. Centers for Disease Control. Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR 1987;36:285&hyph;289. 27. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(2S):1S&hyph;18S. 28. Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;37:377&hyph;382,387&hyph;388. 29. Lynch P, Jackson MM, Cummings J, Stamm, WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107:243&hyph;246. 30. Lynch P, Cummings MJ, Roberts PL, Herriott MJ, Yates B, Stamm WE. Implementing and evaluating a system of generic infection precautions: body substance isolation. Am J Infect Control 1990;18:1&hyph;12. 31. McPherson DC, Jackson MM, Rogers JC. Evaluating the cost of the body substance isolation system. J Healthcare Material Mgmt 1988;6:20&hyph;28. 32. Patterson JE, Vecchio J, Pantelick EL, Farrel P, Mazon D, Zervos MJ, Hierholzer WJ. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med 1991;91:479&hyph;483. 33. Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989;320:1714&hyph;1721. 34. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with gown and glove isolation precautions. N Engl J Med 1987;317:329&hyph;334. 35. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981;70:449&hyph;454. 36. Garner JS, Hierholzer WJ. Controversies in isolation policies and practices. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 2nd ed. Baltimore: Williams & Wilkins, 1993:chap 6:70&hyph;81. 37. Garner JS, Hughes JM. Options for isolation precautions. Ann Intern Med 1987;107:248&hyph;250. 38. Weinstein RA, Kabins SA. Isolation practices in hospitals. Ann Intern Med 1987;107:781&hyph;782. 39. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing. Ann Intern Med 1988;109:394&hyph;398. 40. Sussman GL, Tarlo S, Dolovich J. The spectrum of IgE-mediated response to latex. JAMA 1991;255:2844&hyph;2847. 41. Bubak ME, Reed CE, Fransway AF, et al. Allergic reactions to latex among health-care workers. Mayo Clin Proc 1992;67:1075&hyph;1079. 42. Albert RK, Condie F. Hand-washing patterns in medical intensive care units. N Engl J Med 1981;304:1465&hyph;1466. 43. Preston GA, Larson EL, Stamm WE. The effect of private isolation rooms on patient care practices, colonization and infection in an intensive care unit. Am J Med 1981;70:641&hyph;645. 44. Larson E, Leyden JJ, McGinley KJ, Grove GL, Talbot GH. Physiologic and microbiologic changes in skin related to frequent handwashing. Infect Control 1986;7:59&hyph;63. 45. Department of Labor. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; proposed rule and notice of hearings. Federal Register 1989;54(102):23042&hyph;23139. 46. Doebbeling BN, Wenzel RP. The direct costs of universal precautions in a teaching hospital. JAMA 1990;264:2083&hyph;2087. 47. Eickhoff TC. The cost of prevention. Infect Dis News 1991;4:6. 48. Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145&hyph;153. 49. Klein RS. Universal precautions for preventing occupational exposures to human immunodeficiency virus type 1. Am J Med 1991;90:141&hyph;153. 50. Wong ES, Stotka JL, Chinchilli VM, Williams DS, Stuart CG, Markowitz SM. Are universal precautions effective in reducing the number of occupational exposures among health care workers? JAMA 1991;265:1123&hyph;1128. 51. Department of Labor. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. Federal Register 1991;56(235):64175&hyph;64182. 52. American Hospital Association. OSHA's Final Bloodborne Pathogens Standard: A Special Briefing. American Hospital Association 1992, Item No. 155904. 53. Bruning LM. The bloodborne pathogens final rule. AORN J 1993;57:439&hyph;461. 54. Jackson MM, Lynch P. An attempt to make an issue less murky: a comparison of four systems for infection precautions. Infect Control Hosp Epidemiol 1991;12:448&hyph;450.
